Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xeris Biopharma Holdings (XERS) Debt Ratio (2023 - 2025)

Xeris Biopharma Holdings (XERS) has disclosed Debt Ratio for 3 consecutive years, with 0.57 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio fell 20.04% year-over-year to 0.57, compared with a TTM value of 0.57 through Dec 2025, down 20.04%, and an annual FY2025 reading of 0.57, down 20.04% over the prior year.
  • Debt Ratio was 0.57 for Q4 2025 at Xeris Biopharma Holdings, down from 0.59 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.73 in Q1 2025 and bottomed at 0.0 in Q2 2024.
  • Average Debt Ratio over 3 years is 0.34, with a median of 0.31 recorded in 2023.
  • The sharpest move saw Debt Ratio plummeted 97.5% in 2024, then soared 51494.53% in 2025.
  • Year by year, Debt Ratio stood at 0.59 in 2023, then grew by 21.39% to 0.72 in 2024, then decreased by 20.04% to 0.57 in 2025.
  • Business Quant data shows Debt Ratio for XERS at 0.57 in Q4 2025, 0.59 in Q3 2025, and 0.65 in Q2 2025.